These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23851424)

  • 1. Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial.
    Puskarich MA; Kline JA; Krabill V; Claremont H; Jones AE
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):736-43. PubMed ID: 23851424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial.
    Jones AE; Puskarich MA; Shapiro NI; Guirgis FW; Runyon M; Adams JY; Sherwin R; Arnold R; Roberts BW; Kurz MC; Wang HE; Kline JA; Courtney DM; Trzeciak S; Sterling SA; Nandi U; Patki D; Viele K
    JAMA Netw Open; 2018 Dec; 1(8):e186076. PubMed ID: 30646314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
    François B; Lambden S; Fivez T; Gibot S; Derive M; Grouin JM; Salcedo-Magguilli M; Lemarié J; De Schryver N; Jalkanen V; Hicheur T; Garaud JJ; Cuvier V; Ferrer R; Bestle M; Pettilä V; Mira JP; Bouisse C; Mercier E; Vermassen J; Huberlant V; Vinatier I; Anguel N; Levy M; Laterre PF;
    Lancet Respir Med; 2023 Oct; 11(10):894-904. PubMed ID: 37269870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
    Petsakul S; Morakul S; Tangsujaritvijit V; Kunawut P; Singhatas P; Sanguanwit P
    BMC Anesthesiol; 2020 Nov; 20(1):280. PubMed ID: 33167911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloprost and Organ Dysfunction in Adults With Septic Shock and Endotheliopathy: A Randomized Clinical Trial.
    Bestle MH; Stensballe J; Lange T; Clausen NE; Søe-Jensen P; Pedersen KH; Gybel-Brask M; Kjær MN; Steensen CO; Jensen DB; Gärtner R; Schønemann-Lund M; Kristiansen KT; Lindhardt A; Johansson PI; Perner A
    JAMA Netw Open; 2024 Sep; 7(9):e2432444. PubMed ID: 39259541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous vitamin C administration to patients with septic shock: a pilot randomised controlled trial.
    Rosengrave P; Spencer E; Williman J; Mehrtens J; Morgan S; Doyle T; Van Der Heyden K; Morris A; Shaw G; Carr AC
    Crit Care; 2022 Jan; 26(1):26. PubMed ID: 35073968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabolomics identifies candidate predictor metabolites of an L-carnitine treatment mortality benefit in septic shock.
    Puskarich MA; Jennaro TS; Gillies CE; Evans CR; Karnovsky A; McHugh CE; Flott TL; Jones AE; Stringer KA;
    Clin Transl Sci; 2021 Nov; 14(6):2288-2299. PubMed ID: 34216108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Laterre PF; Pickkers P; Marx G; Wittebole X; Meziani F; Dugernier T; Huberlant V; Schuerholz T; François B; Lascarrou JB; Beishuizen A; Oueslati H; Contou D; Hoiting O; Lacherade JC; Chousterman B; Pottecher J; Bauer M; Godet T; Karakas M; Helms J; Bergmann A; Zimmermann J; Richter K; Hartmann O; Pars M; Mebazaa A;
    Intensive Care Med; 2021 Nov; 47(11):1284-1294. PubMed ID: 34605947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney function as a key driver of the pharmacokinetic response to high-dose L-carnitine in septic shock.
    Jennaro TS; Puskarich MA; Flott TL; McLellan LA; Jones AE; Pai MP; Stringer KA
    Pharmacotherapy; 2023 Dec; 43(12):1240-1250. PubMed ID: 37775945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
    JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
    Patel JJ; Willoughby R; Peterson J; Carver T; Zelten J; Markiewicz A; Spiegelhoff K; Hipp LA; Canales B; Szabo A; Heyland DK; Stoppe C; Zielonka J; Freed JK
    Chest; 2023 Feb; 163(2):303-312. PubMed ID: 36174744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
    Moskowitz A; Huang DT; Hou PC; Gong J; Doshi PB; Grossestreuer AV; Andersen LW; Ngo L; Sherwin RL; Berg KM; Chase M; Cocchi MN; McCannon JB; Hershey M; Hilewitz A; Korotun M; Becker LB; Otero RM; Uduman J; Sen A; Donnino MW;
    JAMA; 2020 Aug; 324(7):642-650. PubMed ID: 32809003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.
    Dhainaut JF; Antonelli M; Wright P; Desachy A; Reignier J; Lavoue S; Charpentier J; Belger M; Cobas-Meyer M; Maier C; Mignini MA; Janes J
    Intensive Care Med; 2009 Jul; 35(7):1187-95. PubMed ID: 19263034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
    Whitehouse T; Hossain A; Perkins GD; Gordon AC; Bion J; Young D; McAuley D; Singer M; Lord J; Gates S; Veenith T; MacCallum NS; Yeung J; Innes R; Welters I; Boota N; Skilton E; Ghuman B; Hill M; Regan SE; Mistry D; Lall R;
    JAMA; 2023 Nov; 330(17):1641-1652. PubMed ID: 37877587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.
    Puskarich MA; Finkel MA; Karnovsky A; Jones AE; Trexel J; Harris BN; Stringer KA
    Ann Am Thorac Soc; 2015 Jan; 12(1):46-56. PubMed ID: 25496487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.
    Lyu QQ; Zheng RQ; Chen QH; Yu JQ; Shao J; Gu XH
    Crit Care; 2022 Sep; 26(1):295. PubMed ID: 36171582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial.
    Yanase F; Spano S; Maeda A; Chaba A; Naorungroj T; Ow CPC; Lankadeva YR; May CN; Betrie AH; Lane DJR; Eastwood GM; Plummer MP; Bellomo R
    Crit Care; 2023 Oct; 27(1):371. PubMed ID: 37828547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.